| |
| |
|
| Insider
Information: |
Hedley Mary Lynne |
| Relationship: |
Director |
| City: |
Lexington |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
34,620 |
|
|
Indirect Shares
|
98 |
|
|
| Direct
Value |
$2,111,492 |
|
|
|
Indirect Value
|
$78,685 |
|
|
| Total
Shares |
34,718 |
|
|
| Total
Value |
$2,190,177 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
MGI Pharma Inc |
MOGN |
Exec VP & Chief Scient... |
2008-01-28 |
0 |
2008-01-23 |
0 |
Premium* |
|
|
New Abraxis Inc |
ABII |
Executive VP of Ops & ... |
2009-07-13 |
25,000 |
2009-07-13 |
0 |
Premium* |
|
|
Tesaro, Inc. |
TSRO |
President & COO, Direc... |
2019-01-22 |
0 |
2019-01-22 |
0 |
Premium* |
|
|
Receptos, Inc. |
RCPT |
Director |
2015-08-27 |
0 |
2015-05-28 |
0 |
Premium* |
|
|
Bluebird Bio, Inc. |
BLUE |
Director |
2018-06-20 |
3,700 |
2017-09-18 |
0 |
Premium* |
|
|
Veeva Systems Inc |
VEEV |
Director |
2024-03-01 |
4,430 |
2019-11-16 |
0 |
Premium* |
|
|
Eli Lilly & Co |
LLY |
Director |
2024-05-20 |
1,490 |
2024-05-20 |
98 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
78 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LLY |
Eli Lilly & Co |
Director |
– • – |
2022-06-21 |
4 |
A |
$297.34 |
$9,812 |
D/D |
33 |
51 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2022-09-19 |
4 |
A |
$305.09 |
$10,068 |
D/D |
33 |
147 |
0 |
- |
|
| VEEV |
Veeva Systems Inc |
Director |
– • – |
2023-12-27 |
4 |
AS |
$190.96 |
$7,829 |
D/D |
(41) |
4,170 |
0 |
% |
|
| VEEV |
Veeva Systems Inc |
Director |
– • – |
2023-12-28 |
4 |
AS |
$191.07 |
$8,025 |
D/D |
(42) |
4,128 |
0 |
% |
|
| VEEV |
Veeva Systems Inc |
Director |
– • – |
2023-07-12 |
4 |
AS |
$207.20 |
$19,062 |
D/D |
(92) |
3,744 |
0 |
% |
|
| VEEV |
Veeva Systems Inc |
Director |
– • – |
2021-07-15 |
4 |
AS |
$314.81 |
$29,592 |
D/D |
(94) |
1,742 |
0 |
% |
|
| VEEV |
Veeva Systems Inc |
Director |
– • – |
2021-01-11 |
4 |
AS |
$288.54 |
$27,411 |
D/D |
(95) |
1,486 |
0 |
% |
|
| VEEV |
Veeva Systems Inc |
Director |
– • – |
2021-04-14 |
4 |
AS |
$270.66 |
$25,713 |
D/D |
(95) |
1,614 |
0 |
% |
|
| VEEV |
Veeva Systems Inc |
Director |
– • – |
2020-06-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
114 |
1,136 |
0 |
- |
|
| VEEV |
Veeva Systems Inc |
Director |
– • – |
2023-07-13 |
4 |
AS |
$208.31 |
$28,747 |
D/D |
(138) |
3,606 |
0 |
% |
|
| VEEV |
Veeva Systems Inc |
Director |
– • – |
2021-09-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
197 |
1,939 |
0 |
- |
|
| VEEV |
Veeva Systems Inc |
Director |
– • – |
2021-12-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
197 |
2,136 |
0 |
- |
|
| VEEV |
Veeva Systems Inc |
Director |
– • – |
2022-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
197 |
2,333 |
0 |
- |
|
| VEEV |
Veeva Systems Inc |
Director |
– • – |
2022-06-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
197 |
2,530 |
0 |
- |
|
| VEEV |
Veeva Systems Inc |
Director |
– • – |
2020-09-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
222 |
1,358 |
0 |
- |
|
| VEEV |
Veeva Systems Inc |
Director |
– • – |
2021-06-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
222 |
1,836 |
0 |
- |
|
| VEEV |
Veeva Systems Inc |
Director |
– • – |
2020-12-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
223 |
1,581 |
0 |
- |
|
| VEEV |
Veeva Systems Inc |
Director |
– • – |
2021-03-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
223 |
1,709 |
0 |
- |
|
| MOGN |
MGI Pharma Inc |
Exec VP & Chief Scientific Off |
• – – |
2006-10-03 |
4 |
D |
$17.21 |
$4,096 |
D/D |
(238) |
23,604 |
0 |
- |
|
| MOGN |
MGI Pharma Inc |
Sr. VP & Chief Scientific Off |
• – – |
2006-07-15 |
4 |
D |
$20.58 |
$5,701 |
D/D |
(277) |
3,223 |
|
- |
|
| MOGN |
MGI Pharma Inc |
Exec VP & Chief Scientific Off |
• – – |
2007-07-15 |
4 |
D |
$25.37 |
$7,053 |
D/D |
(278) |
34,826 |
0 |
- |
|
| VEEV |
Veeva Systems Inc |
Director |
– • – |
2023-09-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
302 |
3,908 |
0 |
- |
|
| VEEV |
Veeva Systems Inc |
Director |
– • – |
2024-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
302 |
4,430 |
0 |
- |
|
| VEEV |
Veeva Systems Inc |
Director |
– • – |
2023-12-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
303 |
4,211 |
0 |
- |
|
| VEEV |
Veeva Systems Inc |
Director |
– • – |
2022-12-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
326 |
3,183 |
0 |
- |
|
78 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
